153 related articles for article (PubMed ID: 12386818)
1. Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells.
Yu Y; Feig LA
Oncogene; 2002 Oct; 21(49):7557-68. PubMed ID: 12386818
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells.
van Agthoven T; van Agthoven TL; Portengen H; Foekens JA; Dorssers LC
Cancer Res; 1992 Sep; 52(18):5082-8. PubMed ID: 1516065
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
5. Ral promotes anchorage-independent growth of a human fibrosarcoma, HT1080.
Yamazaki Y; Kaziro Y; Koide H
Biochem Biophys Res Commun; 2001 Jan; 280(3):868-73. PubMed ID: 11162603
[TBL] [Abstract][Full Text] [Related]
6. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
7. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; RamÃrez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
8. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.
Tseng YH; Vicent D; Zhu J; Niu Y; Adeyinka A; Moyers JS; Watson PH; Kahn CR
Cancer Res; 2001 Mar; 61(5):2071-9. PubMed ID: 11280768
[TBL] [Abstract][Full Text] [Related]
9. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
[TBL] [Abstract][Full Text] [Related]
10. The role of Ral A in epidermal growth factor receptor-regulated cell motility.
Gildea JJ; Harding MA; Seraj MJ; Gulding KM; Theodorescu D
Cancer Res; 2002 Feb; 62(4):982-5. PubMed ID: 11861368
[TBL] [Abstract][Full Text] [Related]
11. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
12. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
Wang HJ; Wu ZY; Fan P; Bian JM
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
[TBL] [Abstract][Full Text] [Related]
13. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
[TBL] [Abstract][Full Text] [Related]
14. Overlapping functions of Ras and Rac GTPases in regulating cancer cell proliferation and invasion.
Crowe DL
Anticancer Res; 2004; 24(2B):593-7. PubMed ID: 15160999
[TBL] [Abstract][Full Text] [Related]
15. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
16. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
17. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
18. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
Chu I; Blackwell K; Chen S; Slingerland J
Cancer Res; 2005 Jan; 65(1):18-25. PubMed ID: 15665275
[TBL] [Abstract][Full Text] [Related]
19. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide activates Rap1 and Ral in a Ras-independent manner.
Mittar D; Sehajpal PK; Lander HM
Biochem Biophys Res Commun; 2004 Sep; 322(1):203-9. PubMed ID: 15313192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
